Diltiazem Infusion Titration from 5 mg/h
Increase the diltiazem infusion from 5 mg/h to 10 mg/h, and if further rate control is needed, titrate up in 5 mg/h increments to a maximum of 15 mg/h. 1
Titration Algorithm
According to the FDA-approved dosing and ACC/AHA/HRS guidelines 2, 1:
Starting from your current 5 mg/h infusion:
- Increase to 10 mg/h if heart rate remains >100 bpm or inadequate rate control
- Further increase to 15 mg/h (maximum dose) if needed for additional rate control
- Titrate in 5 mg/h increments between these doses
The FDA label explicitly states: "The infusion rate may be increased in 5 mg/h increments up to 15 mg/h as needed, if further reduction in heart rate is required" 1. The guideline-recommended infusion range is 5-15 mg/h 2.
Duration and Monitoring
- Maximum infusion duration: 24 hours 1
- Infusion rates >15 mg/h and duration >24 hours have not been studied and are not recommended 1
- Monitor for hypotension, bradycardia, and worsening heart failure during titration 2
Clinical Context
Research demonstrates that 83% of patients maintain therapeutic response with continuous diltiazem infusion at 10-15 mg/h over 24 hours 3. The median effective infusion rate in clinical practice is 10 mg/h 4. Pharmacokinetic studies show diltiazem exhibits dose-dependent, non-linear kinetics with steady-state plasma concentrations achieved during continuous infusion 5.
Critical Precautions
Before titrating up, verify the patient does NOT have:
- Hypotension (relative contraindication) 2
- Decompensated systolic heart failure or LV dysfunction
- AV block greater than first degree (without pacemaker)
- WPW syndrome with atrial fibrillation/flutter
- Concurrent use of other SA/AV nodal blocking agents 2
If hypotension develops during titration, decrease the infusion rate immediately 2.